Relation of prescription nonsteroidal antiinflammatory drug use to cognitive function among community-dwelling elderly

Annals of Epidemiology

Volumn 7, Issue 2, 1997, Pages 87-94

  Hanlon, Joseph T ^a,b,c   Schmader, Kenneth E ^a,b   Landerman, Lawrence R ^a   Horner, Ronnie D ^a   Fillenbaum, Gerda G ^a   Pieper, Carl F ^a   Wall Jr , William E ^a   Koronkowski, Michael J ^c,d   Cohen, Harvey Jay ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

aged; antiinflammatory agents; cognition; cohort studies; memory; Nonsteroidal

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

AGED; AMNESIA; ARTICLE; COGNITIVE DEFECT; COHORT ANALYSIS; DRUG USE; ELDERLY CARE; HUMAN; MAJOR CLINICAL STUDY; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY;

AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COGNITION; COHORT STUDIES; DATA COLLECTION; DATA INTERPRETATION, STATISTICAL; EPIDEMIOLOGIC METHODS; FEMALE; HEALTH STATUS INDICATORS; HUMANS; MALE; MEMORY; MENTAL STATUS SCHEDULE; NEUROPSYCHOLOGICAL TESTS; PROSPECTIVE STUDIES;

EID: 0030903706     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1047-2797(96)00124-X     Document Type: Article

References (66)

1. Baum C, Kennedy DL, Forbes MB. Utilization of nonsteroidal antiinflammatory drugs. Arthritis Rheum. 1985;28:686-692.
2. Gabriel SE, Fehring RA. Trends in the utilization of nonsteroidal and inflammatory drugs in the United States. J Clin Epidemiol. 1992;45:1041-1044.
3. Koch H, Knapp DE. Utilization of analgesic drugs in office-based ambulatory care: National Ambulatory Medical Care Survey 1980-81. Advance Data. 1984:96.
4. Chrischilles EA, Lemke JH, Wallace RB, Drube GA. Prevalence and characteristics of multiple analgesic use in an elderly study group. J Am Geriatr Soc. 1990;30:979-984.
5. Hanlon, JT, Fillenbaum GG, Studenski SA, Ziqubu-Page T, Wall WE. Suboptimal analgesic use in community dwelling elderly. Ann Pharmacother. 1996;30:739-744.
6. Ahonen R, Enlund H, Klahen T, Martikainen J. Consumption of analgesics and antiinflammatory agents in the Nordic countries between 1978-1988. Eur. J Clin Pharmacol. 1991;41:37-42.
7. Hanlon JT, O'Brien JG. Pharmacological management of the elderly patient with terminal cancer pain. J Geriatr Drug Ther. 1989;3:5-30.
8. Portenoy RK, Farkash A. Practical management of non-malignant pain in the elderly. Geriatrics. 1988;43:29-47.
9. Wall RT. Use of analgesics in the elderly. Clin Ger Med 1990;6: 345-364.
10. Murray MD, Brater DC. Nonsteroidal antiinflammatory drugs. Clin Geriatr Med. 1990;6:365-397.
11. Clark DWJ, Ghose K. Neuropsychiatric reactions to nonsteroidal antiinflammatory drugs (NSAIDs): The New Zealand experience. Drug Safety. 1992;7:460-465.
12. Anon. Drugs that cause psychiatric symptoms. Med Lett. 1993;35:65-70.
13. Arnold SE, Kumar A. Reversible dementias. Med Clin North Amer. 1993;77:215-230.
14. Bowen JD, Larson EB. Drug-induced cognitive impairment: defining the problem and finding solutions. Drugs Aging. 1993;3:349-357.
15. Lowenthal DT, Nadeau SE. Drug-induced dementia. South Med J. 1991;84(5S1):24-31.
16. Hoppmann RA, Peden JG, Ober SK. Central nervous system side effects of nonsteroidal antiinflammatory drugs. Arch Intern Med. 1991;151:1309-1313.
17. Morrison RL. Katz IR. Drug-related cognitive impairment. Ann Rev Gerontol Geriatr. 1989;9:232-279.
18. Gotz V. Paranoid psychosis with indomethacin. Br Med J. 1978;1:49.
19. Thornton TL. Delirium associated with sulindac. JAMA. 1980;243:1630-1631.
20. Goodwin JS, Regan M. Cognitive dysfunction associated with naproxen and ibuprofen in the elderly. Arthritis Rheum. 1982;25:1013-1015.
21. Aisen PS, Davis KL. Inflammatory mechanisms in Alzheimer's disease: Implications for therapy. Am J Psychiatry. 1994;151:1105-1113.
22. McGeer PL, Rogers J. Antiinflammatory agents as a therapeutic approach to Alzheimer's disease. Neurology. 1992;42:447-449.
23. Breitner JCS, Gau BA, Welsh KA, Plassman BL, McDonald WM, Helms MJ, et al. Inverse association of antiinflammatory treatments and Alzheimer's disease: initial results of a co-twin control study. Neurology. 1994;44:227-232.
24. Canadian Study of Health and Aging. Risk factors for Alzheimer's disease in Canada. Neurology. 1994;44:2073-2080.
25. Kukall WA, Larson EB, Stergachis A, et al. Nonsteroidal antiiflammatory drug use and risk of Alzheimer's disease [abstract]. Neurology. 1994;44 (S2):A237.
26. Wysenbeek AJ, Klein Z, Nakar S, Mane R. Assessment of cognitive function in elderly patients treated with naproxen. Clin Exp Rheumatol. 1988;6:399-400.
27. Bruce-Jones PNE, Crome P, Kalra L. Indomethacin and cognitive function in healthy elderly volunteers. Br. J Clin Pharmacol. 1994; 38:45-51.
28. May FE, Moore MT, Stewart RB, Hale WE. Lack of association of nonsteroidal anti-inflammatory drug use and cognitive decline in the elderly. Gerontology. 1992;38:275-279.
29. Cornoni-Huntley J, Blazer DG, Lafferty ME, Everett DF, Brock DB, Farmer ME, eds. NIH publication no. 90-495. Established populations for epidemiologic studies of the elderly. Vol 2. Resource Data Book. Bethesda, MD: National Institute on Aging; 1990.
30. Hanlon JT, Fillenbaum GG, Burchett B, et al. Drug use patterns in black and nonblack community dwelling elderly. Ann Pharmacother. 1992;26:679-685.
31. Fillenbaum GG, Hanlon JT, Corder EH, Ziqubu-Page T, Wall WE, Brock D. Prescription and nonprescription drug use among black and white community-residing elderly. Am J Public Health. 1993;83: 1577-1582.
32. Pfeiffer E. A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J Am Geriatr Soc. 1975;23:433-441.
33. DeVito CA, Aldridge GW, Wilson A, Vidis JS, Goldberg T, Dickson WM, et al. Framework and development of a comprehensive drug product coding system. Contemp Pharm Pract. 1979;2:62-65.
34. Helling DK, Lemke JH, Semla TP, Wallace RB, Lipson DP, Cornoni-Huntley J. Medication use characteristics in the elderly: The Iowa 65+ Rural Health Study. J Am Geriatr Soc. 1987;35:4-12.
35. Hanlon JT, Landerman LR, Wall WA, et al. Is medication use by community-dwelling elderly influenced by cognitive function? Age Aging. 1996; 25:190-196.
36. Anon, Drugs for pain. Med Lett. 1993;35:1-6.
37. McEvoy GK, ed. AHFS Drug Information 1993. Bethesda, MD: American Society of Hospital Pharmacists, 1993.
38. Katzman R, Brown T, Fuld P, Peck A, Schechter R, Schimmel H. Validation of a short Orientation-Memory-Concentration test for cognitive impairment. Am J Psychiatry 1983;140:734-739.
39. Fillenbaum G, Heyman A, Williams K, Prosnitz B, Burchett B. Sensitivity and specificity of standardized screens of cognitive impairment and dementia among elderly black and white community residents. J Clin Epidemiol. 1990;43:641-660.
40. Fillenbaum GG. A comparison of two brief tests of organicity: The Mental Status Questionnaire and the Short Portable Mental Status Questionnaire. J Am Geriatr Soc. 1980;28:381-384.
41. Fillenbaum GG, George LK, Blazer DG. Scoring non-response on the Mini-Mental State examination. Psychological Med. 1988;18:1021-1025.
42. Colsher PL, Wallace RB. Epidemiologic considerations in studies of cognitive function in the elderly: methodology and nondementing acquired dysfunction. Epidemiol Rev. 1991;13:1-27.
43. Larson EB, Kukall WA, Katzman RL. Cognitive impairment: Dementia and Alzheimer's disease. Annu Rev Public Health. 1992;13:431-449.
44. White L, Katzman R, Losonczy K, et al. Association of education with incidence of cognitive impairment in three established populations for epidemiologic studies of the elderly. J Clin Epidemiol. 1994;47:363-374.
45. Rosow I, Breslau N. A Guttman health scale for the aged. J Gerontol. 1966; 21:556-559.
46. Radloff LS. The CES-D scale: A self-report depression scale for research use in the general population. Appl Psychiatr Measur. 1977;1:385-401.
47. Blazer D, Burchett B, Service C, George LK. The association of age and depression among the elderly: An epidemiologic exploration. J Gerontol. 1991;46:M210-215.
48. Hebert LE, Scherr PA, Beckett LA, et al. Relation of smoking and low-to-moderate alcohol consumption to change in cognitive function: a longitudinal study in a defined community of older persons. Am J Epidemiol. 1993;137:881-891
49. Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic research: Principles and quantitative methods. New York: Van Nostrand Reinhold, 1982.
50. Kleinbaum DG, Kupper LL, Muller KE. Applied regression analysis and other multivariable methods. 2nd rev, ed. Boston: PWS-Kent Co.; 1988.
51. Neter J, Wasserman W, Kutner MH. Applied linear regression models. Homewood IL: Richard D. Irwin.; 1989.
52. Hosmer D, Lemeshow S. Applied logistic regression. New York: John Wiley; 1989.
53. Chambless LE, Roeback JR. Methods for assessing difference between groups in change when initial measurement is subject to infra-individual variation. Stat Med. 1993; 12:1213-1237.
54. Dixon WJ. BMDP Statistical Software. Berkeley, CA: University of California Press; 1993.
55. SUDAAN: Professional software for survey data analysis. Research Triangle Park, NC: Research Triangle Institute; 1989.
56. SAS/STAT user's guide. Cary, NC: SAS Institute; 1993.
57. Saag KG, Rubenstein LM, Chrischilles EA, Wallace RB. Nonsteroidal antiinflammatory drugs and cognitive decline in the elderly. J Rheumatol. 1995;22:2142-2147.
58. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
59. Sturmer T, Glynn RJ, Field TS, Taylor JO, Hennekens CH. Aspirin use and cognitive function in the elderly. Am J Epidemiol. 1996;:143:683-691.
60. Rozzini R, Ferrucci L, Losonczy K, Havlik RJ, Guralnik JM. Protective effect of chronic NSAID use on cognitive decline in older persons. J Am Geriatr Soc. 1996;44:1025-1029.
61. 2 blocking drugs Neurobiol Aging. 1995;16:523-530.
62. Corrada M, Stewart W, Kawas C. Nonsteroidal anti-inflammatory drugs and the risk of Alzheimer's disease (abstract). Neurology. 1996;46 (S2):A433.
63. Applegate WB, Blass JP, Williams TF. Instruments for the functional assessment of older patients. N Engl J Med. 1990;322:1207-1214.
64. Psaty BM, Lee M, Savage PJ, Rutan GH, German PS, Lyles M. Assessing the use of medications in the elderly: method and initial experience in the Cardiovascular Health Study. J Clin Epidemiol. 1992;45:683-692.
65. West SL, Strom BL, Freundlich B, Koch G, Savitz DA. Completeness of prescription recording in outpatient medical records from a health maintenance organization. J Clin Epidemiol. 1994;47:165-171.
66. Walker AM, Chan KW, Yood RA. Patterns of interchange in the dispensing of nonsteroidal antiinflammatory drugs. J Clin Epidemiol. 1992;45:187-195.